Strox Biopharmaceuticals, Xbiotech deal

XBiotech acquired Strox's patent estate for an undisclosed antibody therapy for methicillin-resistant Staphylococcus aureus (MRSA). XBiotech said the therapy is designed to neutralize an immune evasio...